Physician profile
Sandra L Levitt
NPI 1225224660
$10,378.77
in general payments reported to CMS, 2019-2025
64 companies · $1,419 in 2025
The $1,419 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,457 · 2020: $1,389 · 2021: $1,692 · 2022: $1,602 · 2023: $1,267 · 2024: $1,554 · 2025: $1,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,239.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,745.21 | 2019-2025 | |
| Novo Nordisk INC | $1,273.03 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,213.74 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $631.78 | 2019-2025 | Mounjaro, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $475.01 | 2019-2025 | Xifaxan, Trulance |
| Amgen INC. | $454.86 | 2019-2025 | Otezla, Repatha, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $363.84 | 2019-2023 | Jardiance |
| Pfizer INC. | $291.52 | 2019-2025 | |
| Abbott Laboratories | $277.53 | 2019-2025 | Freestyle Libre 3, Proclaim |
| Nestle Healthcare Nutrition INC. | $265.47 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $258.58 | 2019-2024 | Trintellix |
| Aimmune Therapeutics, INC. | $214.68 | 2024-2025 | Zenpep |
| Merck Sharp & Dohme LLC | $206.12 | 2019-2025 | Gardasil 9, Capvaxive |
| Astellas Pharma US INC | $177.86 | 2021-2025 | Veozah |
| Allergan, INC. | $176.61 | 2019-2020 |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $166.41 | 2019-2023 | Omnipod |
| Amarin Pharma, INC. | $149.70 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $148.26 | 2019-2022 | |
| Boston Scientific Corporation | $133.42 | 2019-2023 | Watchman Flx |
| Sanofi Pasteur INC. | $115.56 | 2019-2023 | |
| Lucid Diagnostics INC. | $101.69 | 2021-2024 | |
| Glaxosmithkline, LLC. | $95.91 | 2020-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Amneal Pharmaceuticals LLC | $89.48 | 2020-2024 | Unithroid |
| Therapeuticsmd, INC. | $87.00 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $74.92 | 2022-2023 | Hetlioz |
| Teva Pharmaceuticals USA, INC. | $69.87 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $69.03 | 2022-2023 | Contrave, Onzetra Xsail |
| Dexcom, INC. | $62.18 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $55.40 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Arbor Pharmaceuticals, INC. | $54.09 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.99 | 2024-2025 | |
| Saluda Medical Americas, INC. | $49.90 | 2023-2024 | Evoke Scs, Evoke |
| Axonics, INC. | $49.90 | 2023-2024 | Axonics |
| Gilead Sciences, INC. | $47.33 | 2022-2024 | Epclusa |
| Horizon Therapeutics Plc | $43.40 | 2020-2021 | |
| Nalu Medical, INC. | $41.37 | 2023-2024 | Nalu Neurostimulation System |
| Bardy Diagnostics, INC. | $38.63 | 2022 | |
| Phathom Pharmaceuticals, INC. | $34.29 | 2024 | Voquezna |
| Idorsia Pharmaceuticals US INC | $32.07 | 2022-2024 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $31.95 | 2021 | |
| Harmony Biosciences LLC | $28.38 | 2024 | |
| Nevro Corp. | $25.47 | 2021 | |
| Baxter Healthcare | $24.89 | 2022 | |
| Edwards Lifesciences Corporation | $24.55 | 2021 | |
| Corcept Therapeutics | $24.43 | 2024 | Korlym |
| Renalytix Ai, INC. | $23.98 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Almatica Pharma LLC | $23.36 | 2024 | Teriparatide, Loreev Xr |
| Shield Therapeutics INC | $22.92 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $21.50 | 2021 | |
| Inspire Medical Systems, INC. | $20.79 | 2025 | Inspire |
| Sumitomo Pharma America, INC. | $20.17 | 2023 | Gemtesa |
| Ibsa Pharma INC. | $19.84 | 2021 | |
| Teleflex LLC | $16.93 | 2022 | |
| Medtronic, INC. | $16.71 | 2023 | Intellis Adaptivestim |
| Biohaven Pharmaceutical Holding Company LTD. | $16.33 | 2022 | |
| Si-Bone, INC. | $16.15 | 2022 | |
| Eisai INC. | $16.07 | 2021 | |
| Impulse Dynamics (USA) INC. | $15.77 | 2022 | |
| Hologic Sales and Service, LLC | $15.46 | 2022 | |
| Intra-Sana Laboratories | $14.89 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Mannkind Corporation | $13.88 | 2019 | |
| Philips North America LLC | $12.98 | 2019 | |
| Azurity Pharmaceuticals, INC. | $12.92 | 2023 | Edarbi |
| Zyla Life Sciences, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Levitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.